Clinical Trial Update: Phase I FOLFOX Combination [Phase 1]

View source ↗

Summary

This update describes a Phase I trial evaluating a FOLFOX chemotherapy combination in advanced colorectal carcinoma, sponsored by Genzyme, which has completed t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Carcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Advanced Colorectal Carcinoma | Phase 1 | Status: COMPLETED